419 related articles for article (PubMed ID: 30578414)
1. Genomic evolution of cancer models: perils and opportunities.
Ben-David U; Beroukhim R; Golub TR
Nat Rev Cancer; 2019 Feb; 19(2):97-109. PubMed ID: 30578414
[TBL] [Abstract][Full Text] [Related]
2. Tumour heterogeneity and resistance to cancer therapies.
Dagogo-Jack I; Shaw AT
Nat Rev Clin Oncol; 2018 Feb; 15(2):81-94. PubMed ID: 29115304
[TBL] [Abstract][Full Text] [Related]
3. The causes and consequences of genetic heterogeneity in cancer evolution.
Burrell RA; McGranahan N; Bartek J; Swanton C
Nature; 2013 Sep; 501(7467):338-45. PubMed ID: 24048066
[TBL] [Abstract][Full Text] [Related]
4. Genomic instability and cancer: lessons from
Gerlach SU; Herranz H
Open Biol; 2020 Jun; 10(6):200060. PubMed ID: 32485126
[TBL] [Abstract][Full Text] [Related]
5. Towards the Delivery of Precision Veterinary Cancer Medicine.
Katogiritis A; Khanna C
Vet Clin North Am Small Anim Pract; 2019 Sep; 49(5):809-818. PubMed ID: 31256903
[TBL] [Abstract][Full Text] [Related]
6. Electromagnetic Fields, Genomic Instability and Cancer: A Systems Biological View.
Naarala J; Kolehmainen M; Juutilainen J
Genes (Basel); 2019 Jun; 10(6):. PubMed ID: 31242701
[TBL] [Abstract][Full Text] [Related]
7. Molecular heterogeneity in lung cancer: from mechanisms of origin to clinical implications.
Zito Marino F; Bianco R; Accardo M; Ronchi A; Cozzolino I; Morgillo F; Rossi G; Franco R
Int J Med Sci; 2019; 16(7):981-989. PubMed ID: 31341411
[TBL] [Abstract][Full Text] [Related]
8. How Darwinian models inform therapeutic failure initiated by clonal heterogeneity in cancer medicine.
Gerlinger M; Swanton C
Br J Cancer; 2010 Oct; 103(8):1139-43. PubMed ID: 20877357
[TBL] [Abstract][Full Text] [Related]
9. Cancer Precision Medicine: Why More Is More and DNA Is Not Enough.
Schütte M; Ogilvie LA; Rieke DT; Lange BMH; Yaspo ML; Lehrach H
Public Health Genomics; 2017; 20(2):70-80. PubMed ID: 28595192
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms and Consequences of Cancer Genome Instability: Lessons from Genome Sequencing Studies.
Lee JK; Choi YL; Kwon M; Park PJ
Annu Rev Pathol; 2016 May; 11():283-312. PubMed ID: 26907526
[TBL] [Abstract][Full Text] [Related]
11. Genomic Instability in Cancer: Teetering on the Limit of Tolerance.
Andor N; Maley CC; Ji HP
Cancer Res; 2017 May; 77(9):2179-2185. PubMed ID: 28432052
[TBL] [Abstract][Full Text] [Related]
12. Clinical and Technical Aspects of Genomic Diagnostics for Precision Oncology.
Sheikine Y; Kuo FC; Lindeman NI
J Clin Oncol; 2017 Mar; 35(9):929-933. PubMed ID: 28297627
[TBL] [Abstract][Full Text] [Related]
13. Drug resistance: origins, evolution and characterization of genomic clones and the tumor ecosystem to optimize precise individualized therapy.
Kyrochristos ID; Ziogas DE; Roukos DH
Drug Discov Today; 2019 Jun; 24(6):1281-1294. PubMed ID: 31009757
[TBL] [Abstract][Full Text] [Related]
14. [Microsatellite instability and cancer: from genomic instability to personalized medicine].
Collura A; Lefevre JH; Svrcek M; Tougeron D; Zaanan A; Duval A
Med Sci (Paris); 2019; 35(6-7):535-543. PubMed ID: 31274083
[TBL] [Abstract][Full Text] [Related]
15. Cancer classification in the genomic era: five contemporary problems.
Song Q; Merajver SD; Li JZ
Hum Genomics; 2015 Oct; 9():27. PubMed ID: 26481255
[TBL] [Abstract][Full Text] [Related]
16. Pathways towards Precision Medicine in Cancer Management Using Genomic Information.
Xie J
J Genet Genomics; 2015 Oct; 42(10):515-516. PubMed ID: 26554905
[No Abstract] [Full Text] [Related]
17. Single Cell Genomics for Tumor Heterogeneity.
Lee HO; Park WY
Adv Exp Med Biol; 2021; 1187():205-214. PubMed ID: 33983580
[TBL] [Abstract][Full Text] [Related]
18. Clinical tumor sequencing: opportunities and challenges for precision cancer medicine.
Damodaran S; Berger MF; Roychowdhury S
Am Soc Clin Oncol Educ Book; 2015; ():e175-82. PubMed ID: 25993170
[TBL] [Abstract][Full Text] [Related]
19. Tumour heterogeneity and the evolution of polyclonal drug resistance.
Burrell RA; Swanton C
Mol Oncol; 2014 Sep; 8(6):1095-111. PubMed ID: 25087573
[TBL] [Abstract][Full Text] [Related]
20. [Genetic instability, a factor limiting the efficiency of targeted therapies in solid oncology].
Billaud A; Chevalier LM; Campone M; Morel A; Bigot F
Bull Cancer; 2020 Nov; 107(11):1161-1170. PubMed ID: 33070953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
